CYBB and Alzheimer disease: VAS2870 displayed low to sustained (40–70%) inhibition against NOX2 and NOX4 but not against NOX5 [131], therefore, although VAS2870 could be a good candidate to be evaluated in AD models, is cytotoxic [135].